Clinical Trial

External Validation of Ten Prediction Models for 30-day Mortality Following Hip Fracture

Study acronym: PROTECT
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 17, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to externally validate ten existing prediction models with a low risk of bias for 30-day mortality following hip fracture. Data will be collected from the Dutch Hip Fracture Audit (DHFA) and supplemented with structured and unstructured data extracted through text mining using CTcue. Approximately 35 clinical variables will be used, including factors consistently associated with short-term mortality. The primary outcome is all-cause mortality within 30 days after hip fracture. Predictive performance will be assessed through discrimination (AUC), explained variance (R²), and calibration analysis. Clinical usefulness will be evaluated using Net Benefit and Decision Curve Analysis. This study seeks to identify models with strong predictive performance and practical applicability to support shared decision-making between clinicians and patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-06.
Trial Details
NCT Number NCT06961253
Lead Sponsor JointResearch
Conditions Hip Fracture, Hip Fracture Surgeries
Enrollment 3,500 participants
Start Date 2024-06-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-17